CCCC — C4 Therapeutics Share News
0.000.00%
Last trade - 00:00- $391.22m
- $137.56m
- $35.95m
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
C4 Therapeutics rises after quarterly revenue beat
C4 Therapeutics Q2 revenue beats estimates, helped by Roche collaboration
Brief: C4 Therapeutics Q2 EPS USD -0.18 Vs. IBES Estimate USD -0.23
C4 Therapeutics, Inc expected to post a loss of 23 cents a share - Earnings Preview
C4 Therapeutics Q1 revenue beats estimates on Biogen milestone payment
Brief: C4 Therapeutics Q1 EPS USD -0.2 Vs. IBES Estimate USD -0.37
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman
U.S. STOCKS ON THE MOVE-Zscaler, Carlyle, Weight Watchers
C4 Therapeutics, Roche expand partnership with new cancer deal worth over $1 billion
U.S. STOCKS ON THE MOVE-Marvell Technology, Tempus AI, Energy Vault
U.S. STOCKS ON THE MOVE-Tesla, CoreWeave, Kymera
C4 Therapeutics gains as Roche signs up to $1 bln cancer drug deal
Brief: C4 Therapeutics Expands Long-Term Partnership With Roche Through New Collaboration Agreement Focused On Discovering And Developing Degrader-Antibody Conjugates (DACs)
Brief: C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule
Brief: C4 Therapeutics Inc Files For Mixed Shelf Of Up To $400 Million - SEC Filing